News
09-25-2011, 10:33 PM
Results from a phase III clinical trial have shown that combining two existing cancer drugs to treat post-menopausal women with advanced breast cancer resistant to hormonal therapy significantly improves outcome.
More... (http://www.news-medical.net/news/20110926/Combination-of-everolimus-exemestane-holds-promise-against-post-menopausal-breast-cancer.aspx)
More... (http://www.news-medical.net/news/20110926/Combination-of-everolimus-exemestane-holds-promise-against-post-menopausal-breast-cancer.aspx)